APA

Coss A., Tosetto M., Fox E. J., Sapetto-Rebow B., Gorman S., Kennedy B. N., Lloyd A. T., Hyland J. M., O'Donoghue D. P., Sheahan K., Leahy D. T., Mulcahy H. E. & O'Sullivan J. N. (20090320). Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis. : Cancer letters.

Chicago

Coss Alan, Tosetto Miriam, Fox Edward J, Sapetto-Rebow Beata, Gorman Sheeona, Kennedy Breandán N, Lloyd Andrew T, Hyland John M, O'Donoghue Diarmuid P, Sheahan Kieran, Leahy Dermot T, Mulcahy Hugh E and O'Sullivan Jacintha N. 20090320. Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis. : Cancer letters.

Harvard

Coss A., Tosetto M., Fox E. J., Sapetto-Rebow B., Gorman S., Kennedy B. N., Lloyd A. T., Hyland J. M., O'Donoghue D. P., Sheahan K., Leahy D. T., Mulcahy H. E. and O'Sullivan J. N. (20090320). Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis. : Cancer letters.

MLA

Coss Alan, Tosetto Miriam, Fox Edward J, Sapetto-Rebow Beata, Gorman Sheeona, Kennedy Breandán N, Lloyd Andrew T, Hyland John M, O'Donoghue Diarmuid P, Sheahan Kieran, Leahy Dermot T, Mulcahy Hugh E and O'Sullivan Jacintha N. Increased topoisomerase IIalpha expression in colorectal cancer is associated with advanced disease and chemotherapeutic resistance via inhibition of apoptosis. : Cancer letters. 20090320.